Skip to content

Micrus Microcoil System Cashmere-Cerecyte, Model CRC; Cashmere-SR, Model SRC

by Micrus Endovascular Corporation

510(k) K072173

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None ongoing

1 closed

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Special NumberK072173 Date5 Oct 2007ClearedStatusActive

Recalls

1 recall · FDA

    • Terminated Z-0845-2011 FDA Unclassified (pre-2012) initiated 21 Oct 2010

    The firm has received reports of difficulty connecting to the detachment control cable. Loss of the electrical connection will result in failure to detach the coil for deployment inside an aneurysm.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
HCG
Device Class
Class II
Regulation
21 CFR Part 882.5950
Advisory Committee
Neurology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Micrus Microcoil System Cashmere-Cerecyte and Cashmere-SR are neurovascular embolization devices classified under the category of neurovascular embolization coils. These devices are intended for the endovascular treatment of intracranial aneurysms by occluding blood flow within the aneurysmal sac, thereby promoting thrombosis and reducing the risk of rupture. The Cashmere-Cerecyte (Model CRC) and Cashmere-SR (Model SRC) models are specifically engineered for precise deployment in neurovascular procedures.

The system is supplied as a sterile, single-use device intended for use in interventional radiology or neurosurgery settings. It requires professional medical personnel to deploy the coils via microcatheters. The device is not MRI-safe and must be used with compatible imaging equipment. Storage conditions are not detailed in the data but generally require protection from moisture and extreme temperatures. The Micrus Microcoil System holds an FDA 510(k) clearance (K072173) for substantial equivalence to predicate devices, affirming its regulatory compliance.

Micrus Microcoil System Cashmere-Cerecyte, Model CRC; Cashmere-SR, Model SRC

Other devices from Micrus Endovascular Corporation

See all devices from Micrus Endovascular Corporation →

Questions

AI-generated answers, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What are the Micrus Cashmere-Cerecyte and Cashmere-SR coils designed for?

    These coils are designed specifically for endovascular treatment of intracranial aneurysms. They work by occluding blood flow within the aneurysm sac, encouraging thrombosis and reducing the risk of rupture. The precise engineering of the Cashmere-Cerecyte (Model CRC) and Cashmere-SR (Model SRC) models ensures accurate deployment during neurovascular procedures.

  • How are the Micrus Microcoil System Cashmere-Cerecyte and Cashmere-SR supplied?

    The system is supplied as a sterile, single-use device. It is intended for professional medical personnel to deploy via microcatheters in interventional radiology or neurosurgery settings. Each coil is packaged individually to maintain sterility until use.

  • Are these coils MRI-safe?

    No, the Micrus Microcoil System Cashmere-Cerecyte and Cashmere-SR coils are not MRI-safe. They must be used with compatible imaging equipment to avoid interference or safety risks during procedures.

  • What storage conditions should be followed for these coils?

    While specific storage instructions are not detailed in the provided data, neurovascular embolization coils generally require protection from moisture and extreme temperatures. Store in a dry, sealed environment away from direct sunlight or heat sources to preserve sterility and integrity.

  • What regulatory clearance does the Micrus Microcoil System hold?

    The device holds an FDA 510(k) clearance (K072173) under substantial equivalence to predicate devices. This clearance confirms regulatory compliance for use in the United States as a neurovascular embolization coil for intracranial aneurysm treatment.